| Title | Journal | Year |  | 
            
                    
                        | Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection 
 |  |  |   | 
                
                    
                        | Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses 
 |  |  |   | 
                
                    
                        | Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial 
 |  |  |   | 
                
                    
                        | CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease 
 |  |  |   | 
                
                    
                        | Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy. 
 |  |  |   | 
                
            
                | View All |